# EXPANSION AND DISTRIBUTION OF NOVEL NGCMS

> **NIH NIH N01** · LEIDOS BIOMEDICAL RESEARCH, INC. · 2020 · $2,129,629

## Abstract

Under this SOW the goal is to fund a central core facility (HCMI contractor) to expand and quality up to 200 different HCMI cancer models during the Period of Performance (POP) of 36 months from existing Cancer Model Development Centers (CMDC’s) as well as from new model contributors. The NGCMs need to be available to the research community for use in any and all experiments and uses.

## Key facts

- **NIH application ID:** 10282477
- **Project number:** 75N91019D00024-0-759102000036-1
- **Recipient organization:** LEIDOS BIOMEDICAL RESEARCH, INC.
- **Principal Investigator:** ETHAN DMITROVSKY
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $2,129,629
- **Award type:** —
- **Project period:** 2020-09-28 → 2023-09-27

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10282477

## Citation

> US National Institutes of Health, RePORTER application 10282477, EXPANSION AND DISTRIBUTION OF NOVEL NGCMS (75N91019D00024-0-759102000036-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10282477. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*